Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 14, 2014 - Issue 11
Submit an article Journal homepage
355
Views
11
CrossRef citations to date
0
Altmetric
Drug Profile

Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis

Irene Moreno TorresHospital Universitario Puerta de Hierro, Laboratorio de Neuroinmunologia, Majadahonda, 28222, Spain
,
Antonio J SanchezHospital Universitario Puerta de Hierro, Neurologia, Unidad de Neuroinmunologia, Majadahonda, 28222, Spain
&
Antonio Garcia-MerinoHospital Universitario Puerta de Hierro, Laboratorio de Neuroinmunologia, Majadahonda, 28222, SpainCorrespondence[email protected]
Pages 1243-1250 | Published online: 21 Oct 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mauro Maccarrone, Rafael Maldonado, Miguel Casas, Thomas Henze & Diego Centonze. (2017) Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?. Expert Review of Clinical Pharmacology 10:4, pages 443-455.
Read now
Adrien Gras & Julie Broughton. (2016) A cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis. Expert Review of Pharmacoeconomics & Outcomes Research 16:6, pages 771-779.
Read now

Articles from other publishers (9)

Carmen Martinez-PazEmilio García-Cabrera & Ángel Vilches-Arenas. (2023) Effectiveness and Safety of Cannabinoids as an Add-On Therapy in the Treatment of Resistant Spasticity in Multiple Sclerosis: A Systematic Review. Cannabis and Cannabinoid Research 8:4, pages 580-588.
Crossref
Wessam Mustafa, Nadia Elgendy, Samer Salama, Mohamed Jawad & Khaled Eltoukhy. (2021) The Effect of Cannabis on the Clinical and Cytokine Profiles in Patients with Multiple Sclerosis. Multiple Sclerosis International 2021, pages 1-10.
Crossref
Hayes Wong & Brian E. Cairns. (2019) Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain. Archives of Oral Biology 104, pages 33-39.
Crossref
Irene Moreno-Torres, Julia Sabín-Muñoz & Antonio García-Merino. 2019. Emerging Drugs and Targets for Multiple Sclerosis. Emerging Drugs and Targets for Multiple Sclerosis 1 32 .
Coral González-García, Irene Moreno Torres, Ruth García-Hernández, Lucía Campos-Ruíz, Luis Rodríguez Esparragoza, María José Coronado, Aranzazu García Grande, Antonio García-Merino & Antonio J. Sánchez López. (2017) Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis. Experimental Neurology 298, pages 57-67.
Crossref
Pasquale Annunziata, Chiara Cioni, Claudia Mugnaini & Federico Corelli. (2017) Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis. Journal of Neuroimmunology 303, pages 66-74.
Crossref
Uwe K. Zettl, Paulus Rommer, Petra Hipp & Robert Patejdl. (2015) Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis. Therapeutic Advances in Neurological Disorders 9:1, pages 9-30.
Crossref
Paulus Stefan Rommer, Frank Kamin, Mazen Abu‐Mugheisib, Wolfgang Koehler, Frank Hoffmann, Alexander Winkelmann, Reiner Benecke & Uwe Klaus Zettl. (2015) Long‐Term Effects of Repeated Cycles of Intrathecal Triamcinolone Acetonide on Spasticity in MS Patients . CNS Neuroscience & Therapeutics 22:1, pages 74-79.
Crossref
S M Todd & J C Arnold. (2016) Neural correlates of interactions between cannabidiol and Δ 9 -tetrahydrocannabinol in mice: implications for medical cannabis . British Journal of Pharmacology 173:1, pages 53-65.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.